- GenFleet will present preclinical research data on three RAS pathway-targeted therapies at the 2026 AACR Annual Meeting in San Diego, running April 17-22, 2026.
- Poster presentations are scheduled for April 19, 2026 and April 21, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics (Shanghai) Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260320-12061512), on March 20, 2026, and is solely responsible for the information contained therein.
Comments